2019
DOI: 10.1002/bab.1749
|View full text |Cite
|
Sign up to set email alerts
|

Improving the cost effectiveness of enhanced green fluorescent protein production using recombinant Escherichia coli BL21 (DE3): Decreasing the expression inducer concentration

Abstract: Green fluorescent protein (GFP) is a globular protein used as biosensor and biomarker in medical and industrial fields. However, due to the expensive production costs of expressing proteins using high-cost inducers like isopropyl-β-D-1thiogalactopyranoside (IPTG), the number of GFP applications are still scarce. This work studied the production of enhanced GFP (EGFP) using Escherichia coli BL21 (DE3) [pLysS; pET28(a)], aiming to increase its yield and reduce costs. First, the influence of agitation rate, induc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 51 publications
(65 reference statements)
0
5
0
Order By: Relevance
“…In the last years, some studies are aiming to decrease GFP price by developing new ways to produce it successfully [15,16]. Mainly two strategies are in place, with the first one focusing on improvements in upstream processes by obtaining high titres using recombinant Escherichia coli, the current available commercial product, [17] or tobacco plants [18] to express the protein. Alternatively, there are also studies aiming to reduce costs by improving the recovery and purification techniques in the downstream process as they can represent a large fraction of the production costs [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…In the last years, some studies are aiming to decrease GFP price by developing new ways to produce it successfully [15,16]. Mainly two strategies are in place, with the first one focusing on improvements in upstream processes by obtaining high titres using recombinant Escherichia coli, the current available commercial product, [17] or tobacco plants [18] to express the protein. Alternatively, there are also studies aiming to reduce costs by improving the recovery and purification techniques in the downstream process as they can represent a large fraction of the production costs [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…When IPTG is added at low cell densities, the metabolism of the target protein is assumed to harm normal bacterial growth under normal pH condition value 7.0, leading to a decrease in OD 600 [40,41]. Similarly, in this study, when 200 mM IPTG was added during LLP, the recombinant plasmid was activated prematurely and cell growth was retarded thereby negatively affecting D-LA biosynthesis, and the concentration of D-LA was reduced to 36.4 g•L −1 (Figure 4A).…”
Section: Inductional Effect On D-la Synthesis At Different Growth Stagesmentioning
confidence: 99%
“…The total protein content of the fermentation was calculated as 75.3 mg L À1 in E. coli BL21 (DE3) culture broth, an amount which was consistent with previously reported yields. 63,64 According to the uorescence and peak area of the HPLC analysis, the protein purity was determined >95%.…”
Section: Cloning and Expression Of His6-sumo-sfgfp-chbd Genesmentioning
confidence: 99%